nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—ABCG2—Zafirlukast—asthma	0.0807	0.117	CbGbCtD
Topotecan—ABCB1—Fluticasone furoate—asthma	0.0489	0.0711	CbGbCtD
Topotecan—ABCB1—Indacaterol—asthma	0.0399	0.058	CbGbCtD
Topotecan—ABCG2—Hydrocortisone—asthma	0.0329	0.0477	CbGbCtD
Topotecan—CYP3A4—Fluticasone furoate—asthma	0.0293	0.0426	CbGbCtD
Topotecan—CYP3A4—Budesonide—asthma	0.0261	0.038	CbGbCtD
Topotecan—CYP3A4—Ciclesonide—asthma	0.0239	0.0347	CbGbCtD
Topotecan—CYP3A4—Indacaterol—asthma	0.0239	0.0347	CbGbCtD
Topotecan—CYP3A4—Salmeterol—asthma	0.0222	0.0323	CbGbCtD
Topotecan—CYP3A4—Flunisolide—asthma	0.0222	0.0323	CbGbCtD
Topotecan—CYP3A4—Salbutamol—asthma	0.0222	0.0323	CbGbCtD
Topotecan—ABCB1—Loratadine—asthma	0.0213	0.0309	CbGbCtD
Topotecan—ABCG2—Dexamethasone—asthma	0.0204	0.0297	CbGbCtD
Topotecan—CYP3A4—Zileuton—asthma	0.0198	0.0288	CbGbCtD
Topotecan—CYP3A4—Ipratropium bromide—asthma	0.0198	0.0288	CbGbCtD
Topotecan—ABCB1—Methylprednisolone—asthma	0.0195	0.0283	CbGbCtD
Topotecan—CYP3A4—Fluticasone Propionate—asthma	0.0189	0.0274	CbGbCtD
Topotecan—CYP3A4—Zafirlukast—asthma	0.0174	0.0253	CbGbCtD
Topotecan—CYP3A4—Tiotropium—asthma	0.015	0.0218	CbGbCtD
Topotecan—CYP3A4—Aminophylline—asthma	0.0143	0.0208	CbGbCtD
Topotecan—CYP3A4—Theophylline—asthma	0.0135	0.0196	CbGbCtD
Topotecan—CYP3A4—Loratadine—asthma	0.0128	0.0185	CbGbCtD
Topotecan—CYP3A4—Montelukast—asthma	0.0128	0.0185	CbGbCtD
Topotecan—ABCB1—Betamethasone—asthma	0.0127	0.0184	CbGbCtD
Topotecan—ABCB1—Prednisolone—asthma	0.0125	0.0182	CbGbCtD
Topotecan—ABCB1—Hydrocortisone—asthma	0.0119	0.0172	CbGbCtD
Topotecan—ABCB1—Prednisone—asthma	0.0118	0.0171	CbGbCtD
Topotecan—CYP3A4—Methylprednisolone—asthma	0.0117	0.017	CbGbCtD
Topotecan—CYP3A4—Triamcinolone—asthma	0.00885	0.0129	CbGbCtD
Topotecan—CYP3A4—Betamethasone—asthma	0.00759	0.011	CbGbCtD
Topotecan—CYP3A4—Prednisolone—asthma	0.00749	0.0109	CbGbCtD
Topotecan—ABCB1—Dexamethasone—asthma	0.00737	0.0107	CbGbCtD
Topotecan—CYP3A4—Hydrocortisone—asthma	0.0071	0.0103	CbGbCtD
Topotecan—CYP3A4—Prednisone—asthma	0.00707	0.0103	CbGbCtD
Topotecan—TOP1MT—respiratory system—asthma	0.00625	0.189	CbGeAlD
Topotecan—CYP3A4—Dexamethasone—asthma	0.00442	0.00641	CbGbCtD
Topotecan—TOP1MT—adrenal gland—asthma	0.00378	0.115	CbGeAlD
Topotecan—TOP1MT—lung—asthma	0.00332	0.1	CbGeAlD
Topotecan—TOP1—adrenal cortex—asthma	0.00277	0.0837	CbGeAlD
Topotecan—TOP1—bronchus—asthma	0.00271	0.0821	CbGeAlD
Topotecan—TOP1—smooth muscle tissue—asthma	0.00265	0.0803	CbGeAlD
Topotecan—TOP1—trachea—asthma	0.00244	0.0737	CbGeAlD
Topotecan—TOP1—adrenal gland—asthma	0.002	0.0604	CbGeAlD
Topotecan—TOP1—lung—asthma	0.00175	0.053	CbGeAlD
Topotecan—ABCG2—adrenal cortex—asthma	0.000981	0.0297	CbGeAlD
Topotecan—Irinotecan—ALB—asthma	0.000854	1	CrCbGaD
Topotecan—ABCG2—adrenal gland—asthma	0.000708	0.0214	CbGeAlD
Topotecan—ABCG2—lung—asthma	0.000621	0.0188	CbGeAlD
Topotecan—ABCB1—respiratory system—asthma	0.000577	0.0175	CbGeAlD
Topotecan—TOP1—Caspase Cascade in Apoptosis—PRF1—asthma	0.000521	0.0868	CbGpPWpGaD
Topotecan—ABCB1—adrenal cortex—asthma	0.000484	0.0146	CbGeAlD
Topotecan—ABCB1—epithelium—asthma	0.000482	0.0146	CbGeAlD
Topotecan—ABCB1—cardiovascular system—asthma	0.000442	0.0134	CbGeAlD
Topotecan—ABCB1—trachea—asthma	0.000426	0.0129	CbGeAlD
Topotecan—ABCB1—adrenal gland—asthma	0.000349	0.0106	CbGeAlD
Topotecan—TOP1—Caspase Cascade in Apoptosis—PARP1—asthma	0.000336	0.0559	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—PRMT5—asthma	0.000316	0.0526	CbGpPWpGaD
Topotecan—ABCB1—lung—asthma	0.000306	0.00927	CbGeAlD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—RAD50—asthma	0.000222	0.037	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—IL1R1—asthma	0.000198	0.033	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—PRF1—asthma	0.00019	0.0317	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—UTS2—asthma	0.000181	0.0302	CbGpPWpGaD
Topotecan—TOP1—Caspase Cascade in Apoptosis—BCL2—asthma	0.000146	0.0243	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—NPS—asthma	0.000132	0.0219	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—ESR2—asthma	0.000121	0.0201	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—IL3—asthma	0.000119	0.0198	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	0.000107	0.0178	CbGpPWpGaD
Topotecan—Angiopathy—Methylprednisolone—asthma	0.000106	0.00039	CcSEcCtD
Topotecan—Nausea—Mometasone—asthma	0.000106	0.000389	CcSEcCtD
Topotecan—Immune system disorder—Methylprednisolone—asthma	0.000105	0.000388	CcSEcCtD
Topotecan—Rash—Arformoterol—asthma	0.000105	0.000387	CcSEcCtD
Topotecan—Rash—Formoterol—asthma	0.000105	0.000387	CcSEcCtD
Topotecan—Mediastinal disorder—Methylprednisolone—asthma	0.000105	0.000387	CcSEcCtD
Topotecan—Dermatitis—Arformoterol—asthma	0.000105	0.000387	CcSEcCtD
Topotecan—Dermatitis—Formoterol—asthma	0.000105	0.000387	CcSEcCtD
Topotecan—Weight increased—Prednisone—asthma	0.000105	0.000387	CcSEcCtD
Topotecan—Headache—Arformoterol—asthma	0.000105	0.000385	CcSEcCtD
Topotecan—Headache—Formoterol—asthma	0.000105	0.000385	CcSEcCtD
Topotecan—Diarrhoea—Budesonide—asthma	0.000104	0.000384	CcSEcCtD
Topotecan—Dizziness—Salbutamol—asthma	0.000104	0.000383	CcSEcCtD
Topotecan—Vomiting—Montelukast—asthma	0.000104	0.000382	CcSEcCtD
Topotecan—Rash—Montelukast—asthma	0.000103	0.000379	CcSEcCtD
Topotecan—Dermatitis—Montelukast—asthma	0.000103	0.000379	CcSEcCtD
Topotecan—Ill-defined disorder—Prednisolone—asthma	0.000103	0.000378	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—NTRK1—asthma	0.000102	0.0171	CbGpPWpGaD
Topotecan—Headache—Montelukast—asthma	0.000102	0.000377	CcSEcCtD
Topotecan—Malnutrition—Methylprednisolone—asthma	0.000102	0.000374	CcSEcCtD
Topotecan—Angioedema—Prednisolone—asthma	0.000101	0.000372	CcSEcCtD
Topotecan—Neuropathy peripheral—Prednisone—asthma	0.000101	0.000371	CcSEcCtD
Topotecan—Dizziness—Budesonide—asthma	0.000101	0.000371	CcSEcCtD
Topotecan—Ill-defined disorder—Hydrocortisone—asthma	0.0001	0.000369	CcSEcCtD
Topotecan—Vomiting—Salbutamol—asthma	0.0001	0.000369	CcSEcCtD
Topotecan—Malaise—Prednisolone—asthma	9.99e-05	0.000368	CcSEcCtD
Topotecan—Rash—Salbutamol—asthma	9.94e-05	0.000366	CcSEcCtD
Topotecan—Dermatitis—Salbutamol—asthma	9.93e-05	0.000365	CcSEcCtD
Topotecan—Nausea—Formoterol—asthma	9.91e-05	0.000365	CcSEcCtD
Topotecan—Nausea—Arformoterol—asthma	9.91e-05	0.000365	CcSEcCtD
Topotecan—Angioedema—Hydrocortisone—asthma	9.88e-05	0.000364	CcSEcCtD
Topotecan—Headache—Salbutamol—asthma	9.87e-05	0.000363	CcSEcCtD
Topotecan—Back pain—Triamcinolone—asthma	9.85e-05	0.000363	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—BDNF—asthma	9.77e-05	0.0163	CbGpPWpGaD
Topotecan—Malaise—Hydrocortisone—asthma	9.75e-05	0.000359	CcSEcCtD
Topotecan—Nausea—Montelukast—asthma	9.71e-05	0.000357	CcSEcCtD
Topotecan—Vomiting—Budesonide—asthma	9.7e-05	0.000357	CcSEcCtD
Topotecan—Angiopathy—Dexamethasone—asthma	9.63e-05	0.000354	CcSEcCtD
Topotecan—Angiopathy—Betamethasone—asthma	9.63e-05	0.000354	CcSEcCtD
Topotecan—Rash—Budesonide—asthma	9.62e-05	0.000354	CcSEcCtD
Topotecan—Dermatitis—Budesonide—asthma	9.61e-05	0.000354	CcSEcCtD
Topotecan—Headache—Budesonide—asthma	9.56e-05	0.000352	CcSEcCtD
Topotecan—Ill-defined disorder—Triamcinolone—asthma	9.45e-05	0.000348	CcSEcCtD
Topotecan—Ill-defined disorder—Methylprednisolone—asthma	9.43e-05	0.000347	CcSEcCtD
Topotecan—Alopecia—Betamethasone—asthma	9.38e-05	0.000345	CcSEcCtD
Topotecan—Alopecia—Dexamethasone—asthma	9.38e-05	0.000345	CcSEcCtD
Topotecan—Nausea—Salbutamol—asthma	9.36e-05	0.000344	CcSEcCtD
Topotecan—TOP1—Caspase Cascade in Apoptosis—TNF—asthma	9.34e-05	0.0156	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	9.32e-05	0.0155	CbGpPWpGaD
Topotecan—Discomfort—Prednisolone—asthma	9.31e-05	0.000343	CcSEcCtD
Topotecan—Angioedema—Triamcinolone—asthma	9.31e-05	0.000342	CcSEcCtD
Topotecan—Haemoglobin—Prednisone—asthma	9.29e-05	0.000342	CcSEcCtD
Topotecan—Angioedema—Methylprednisolone—asthma	9.28e-05	0.000342	CcSEcCtD
Topotecan—Haemorrhage—Prednisone—asthma	9.24e-05	0.00034	CcSEcCtD
Topotecan—Myalgia—Hydrocortisone—asthma	9.21e-05	0.000339	CcSEcCtD
Topotecan—Malaise—Triamcinolone—asthma	9.18e-05	0.000338	CcSEcCtD
Topotecan—Malaise—Methylprednisolone—asthma	9.16e-05	0.000337	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	9.14e-05	0.000337	CcSEcCtD
Topotecan—Discomfort—Hydrocortisone—asthma	9.1e-05	0.000335	CcSEcCtD
Topotecan—Nausea—Budesonide—asthma	9.07e-05	0.000334	CcSEcCtD
Topotecan—Anaphylactic shock—Prednisolone—asthma	9.04e-05	0.000333	CcSEcCtD
Topotecan—Cough—Triamcinolone—asthma	8.89e-05	0.000327	CcSEcCtD
Topotecan—Anaphylactic shock—Hydrocortisone—asthma	8.83e-05	0.000325	CcSEcCtD
Topotecan—Infection—Hydrocortisone—asthma	8.77e-05	0.000323	CcSEcCtD
Topotecan—Hyperhidrosis—Prednisolone—asthma	8.74e-05	0.000322	CcSEcCtD
Topotecan—Myalgia—Triamcinolone—asthma	8.67e-05	0.000319	CcSEcCtD
Topotecan—Nervous system disorder—Hydrocortisone—asthma	8.66e-05	0.000319	CcSEcCtD
Topotecan—Arthralgia—Methylprednisolone—asthma	8.65e-05	0.000318	CcSEcCtD
Topotecan—Myalgia—Methylprednisolone—asthma	8.65e-05	0.000318	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	8.59e-05	0.000316	CcSEcCtD
Topotecan—Skin disorder—Hydrocortisone—asthma	8.57e-05	0.000316	CcSEcCtD
Topotecan—Ill-defined disorder—Betamethasone—asthma	8.57e-05	0.000316	CcSEcCtD
Topotecan—Ill-defined disorder—Dexamethasone—asthma	8.57e-05	0.000316	CcSEcCtD
Topotecan—Discomfort—Triamcinolone—asthma	8.57e-05	0.000315	CcSEcCtD
Topotecan—Discomfort—Methylprednisolone—asthma	8.55e-05	0.000315	CcSEcCtD
Topotecan—Hyperhidrosis—Hydrocortisone—asthma	8.53e-05	0.000314	CcSEcCtD
Topotecan—Angioedema—Dexamethasone—asthma	8.44e-05	0.000311	CcSEcCtD
Topotecan—Angioedema—Betamethasone—asthma	8.44e-05	0.000311	CcSEcCtD
Topotecan—Anorexia—Hydrocortisone—asthma	8.41e-05	0.00031	CcSEcCtD
Topotecan—Angiopathy—Prednisone—asthma	8.39e-05	0.000309	CcSEcCtD
Topotecan—Immune system disorder—Prednisone—asthma	8.35e-05	0.000307	CcSEcCtD
Topotecan—Malaise—Betamethasone—asthma	8.33e-05	0.000307	CcSEcCtD
Topotecan—Malaise—Dexamethasone—asthma	8.33e-05	0.000307	CcSEcCtD
Topotecan—CYP3A4—Aflatoxin B1 metabolism—GSTM1—asthma	8.32e-05	0.0139	CbGpPWpGaD
Topotecan—Anaphylactic shock—Triamcinolone—asthma	8.31e-05	0.000306	CcSEcCtD
Topotecan—Anaphylactic shock—Methylprednisolone—asthma	8.29e-05	0.000305	CcSEcCtD
Topotecan—Infection—Triamcinolone—asthma	8.26e-05	0.000304	CcSEcCtD
Topotecan—Infection—Methylprednisolone—asthma	8.24e-05	0.000303	CcSEcCtD
Topotecan—Alopecia—Prednisone—asthma	8.17e-05	0.000301	CcSEcCtD
Topotecan—Nervous system disorder—Methylprednisolone—asthma	8.13e-05	0.000299	CcSEcCtD
Topotecan—Paraesthesia—Prednisolone—asthma	8.12e-05	0.000299	CcSEcCtD
Topotecan—Skin disorder—Methylprednisolone—asthma	8.05e-05	0.000296	CcSEcCtD
Topotecan—Malnutrition—Prednisone—asthma	8.05e-05	0.000296	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Hydrocortisone—asthma	8.04e-05	0.000296	CcSEcCtD
Topotecan—Hyperhidrosis—Triamcinolone—asthma	8.03e-05	0.000296	CcSEcCtD
Topotecan—Hyperhidrosis—Methylprednisolone—asthma	8.02e-05	0.000295	CcSEcCtD
Topotecan—Paraesthesia—Hydrocortisone—asthma	7.93e-05	0.000292	CcSEcCtD
Topotecan—Myalgia—Betamethasone—asthma	7.87e-05	0.00029	CcSEcCtD
Topotecan—Myalgia—Dexamethasone—asthma	7.87e-05	0.00029	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDK2—asthma	7.78e-05	0.013	CbGpPWpGaD
Topotecan—Discomfort—Dexamethasone—asthma	7.77e-05	0.000286	CcSEcCtD
Topotecan—Discomfort—Betamethasone—asthma	7.77e-05	0.000286	CcSEcCtD
Topotecan—Dyspepsia—Hydrocortisone—asthma	7.77e-05	0.000286	CcSEcCtD
Topotecan—Pain—Prednisolone—asthma	7.73e-05	0.000284	CcSEcCtD
Topotecan—Decreased appetite—Hydrocortisone—asthma	7.67e-05	0.000282	CcSEcCtD
Topotecan—CYP3A4—Tryptophan metabolism—PRMT1—asthma	7.65e-05	0.0128	CbGpPWpGaD
Topotecan—Gastrointestinal disorder—Hydrocortisone—asthma	7.62e-05	0.00028	CcSEcCtD
Topotecan—Fatigue—Hydrocortisone—asthma	7.61e-05	0.00028	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Triamcinolone—asthma	7.57e-05	0.000279	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Methylprednisolone—asthma	7.56e-05	0.000278	CcSEcCtD
Topotecan—Pain—Hydrocortisone—asthma	7.55e-05	0.000278	CcSEcCtD
Topotecan—Anaphylactic shock—Dexamethasone—asthma	7.54e-05	0.000278	CcSEcCtD
Topotecan—Anaphylactic shock—Betamethasone—asthma	7.54e-05	0.000278	CcSEcCtD
Topotecan—Infection—Betamethasone—asthma	7.49e-05	0.000276	CcSEcCtD
Topotecan—Infection—Dexamethasone—asthma	7.49e-05	0.000276	CcSEcCtD
Topotecan—Ill-defined disorder—Prednisone—asthma	7.47e-05	0.000275	CcSEcCtD
Topotecan—Paraesthesia—Triamcinolone—asthma	7.46e-05	0.000275	CcSEcCtD
Topotecan—Feeling abnormal—Prednisolone—asthma	7.45e-05	0.000274	CcSEcCtD
Topotecan—Paraesthesia—Methylprednisolone—asthma	7.45e-05	0.000274	CcSEcCtD
Topotecan—Anaemia—Prednisone—asthma	7.44e-05	0.000274	CcSEcCtD
Topotecan—Dyspnoea—Triamcinolone—asthma	7.41e-05	0.000273	CcSEcCtD
Topotecan—Nervous system disorder—Dexamethasone—asthma	7.4e-05	0.000272	CcSEcCtD
Topotecan—Nervous system disorder—Betamethasone—asthma	7.4e-05	0.000272	CcSEcCtD
Topotecan—Thrombocytopenia—Dexamethasone—asthma	7.38e-05	0.000272	CcSEcCtD
Topotecan—Thrombocytopenia—Betamethasone—asthma	7.38e-05	0.000272	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—LEP—asthma	7.37e-05	0.0123	CbGpPWpGaD
Topotecan—Angioedema—Prednisone—asthma	7.35e-05	0.000271	CcSEcCtD
Topotecan—Dyspepsia—Triamcinolone—asthma	7.32e-05	0.000269	CcSEcCtD
Topotecan—Dyspepsia—Methylprednisolone—asthma	7.3e-05	0.000269	CcSEcCtD
Topotecan—Hyperhidrosis—Dexamethasone—asthma	7.29e-05	0.000268	CcSEcCtD
Topotecan—Hyperhidrosis—Betamethasone—asthma	7.29e-05	0.000268	CcSEcCtD
Topotecan—Feeling abnormal—Hydrocortisone—asthma	7.27e-05	0.000268	CcSEcCtD
Topotecan—Malaise—Prednisone—asthma	7.26e-05	0.000267	CcSEcCtD
Topotecan—Gastrointestinal pain—Hydrocortisone—asthma	7.22e-05	0.000266	CcSEcCtD
Topotecan—Anorexia—Betamethasone—asthma	7.19e-05	0.000265	CcSEcCtD
Topotecan—Anorexia—Dexamethasone—asthma	7.19e-05	0.000265	CcSEcCtD
Topotecan—Urticaria—Prednisolone—asthma	7.18e-05	0.000264	CcSEcCtD
Topotecan—Fatigue—Triamcinolone—asthma	7.17e-05	0.000264	CcSEcCtD
Topotecan—Fatigue—Methylprednisolone—asthma	7.15e-05	0.000263	CcSEcCtD
Topotecan—Pain—Triamcinolone—asthma	7.11e-05	0.000262	CcSEcCtD
Topotecan—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—asthma	7.09e-05	0.0118	CbGpPWpGaD
Topotecan—Urticaria—Hydrocortisone—asthma	7.01e-05	0.000258	CcSEcCtD
Topotecan—Body temperature increased—Hydrocortisone—asthma	6.98e-05	0.000257	CcSEcCtD
Topotecan—Abdominal pain—Hydrocortisone—asthma	6.98e-05	0.000257	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Betamethasone—asthma	6.87e-05	0.000253	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Dexamethasone—asthma	6.87e-05	0.000253	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—NOS2—asthma	6.86e-05	0.0114	CbGpPWpGaD
Topotecan—Arthralgia—Prednisone—asthma	6.85e-05	0.000252	CcSEcCtD
Topotecan—Myalgia—Prednisone—asthma	6.85e-05	0.000252	CcSEcCtD
Topotecan—Feeling abnormal—Triamcinolone—asthma	6.85e-05	0.000252	CcSEcCtD
Topotecan—Feeling abnormal—Methylprednisolone—asthma	6.83e-05	0.000251	CcSEcCtD
Topotecan—ABCB1—Drug Induction of Bile Acid Pathway—VDR—asthma	6.83e-05	0.0114	CbGpPWpGaD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	6.8e-05	0.00025	CcSEcCtD
Topotecan—Gastrointestinal pain—Methylprednisolone—asthma	6.78e-05	0.00025	CcSEcCtD
Topotecan—Paraesthesia—Dexamethasone—asthma	6.77e-05	0.000249	CcSEcCtD
Topotecan—Paraesthesia—Betamethasone—asthma	6.77e-05	0.000249	CcSEcCtD
Topotecan—Discomfort—Prednisone—asthma	6.77e-05	0.000249	CcSEcCtD
Topotecan—Hypersensitivity—Prednisolone—asthma	6.66e-05	0.000245	CcSEcCtD
Topotecan—Dyspepsia—Betamethasone—asthma	6.64e-05	0.000244	CcSEcCtD
Topotecan—Dyspepsia—Dexamethasone—asthma	6.64e-05	0.000244	CcSEcCtD
Topotecan—Urticaria—Triamcinolone—asthma	6.6e-05	0.000243	CcSEcCtD
Topotecan—Urticaria—Methylprednisolone—asthma	6.59e-05	0.000242	CcSEcCtD
Topotecan—Body temperature increased—Triamcinolone—asthma	6.57e-05	0.000242	CcSEcCtD
Topotecan—Anaphylactic shock—Prednisone—asthma	6.57e-05	0.000242	CcSEcCtD
Topotecan—Abdominal pain—Methylprednisolone—asthma	6.56e-05	0.000241	CcSEcCtD
Topotecan—Decreased appetite—Dexamethasone—asthma	6.56e-05	0.000241	CcSEcCtD
Topotecan—Decreased appetite—Betamethasone—asthma	6.56e-05	0.000241	CcSEcCtD
Topotecan—Infection—Prednisone—asthma	6.52e-05	0.00024	CcSEcCtD
Topotecan—Gastrointestinal disorder—Betamethasone—asthma	6.51e-05	0.00024	CcSEcCtD
Topotecan—Gastrointestinal disorder—Dexamethasone—asthma	6.51e-05	0.00024	CcSEcCtD
Topotecan—Hypersensitivity—Hydrocortisone—asthma	6.5e-05	0.000239	CcSEcCtD
Topotecan—Fatigue—Dexamethasone—asthma	6.5e-05	0.000239	CcSEcCtD
Topotecan—Fatigue—Betamethasone—asthma	6.5e-05	0.000239	CcSEcCtD
Topotecan—Pain—Dexamethasone—asthma	6.45e-05	0.000237	CcSEcCtD
Topotecan—Pain—Betamethasone—asthma	6.45e-05	0.000237	CcSEcCtD
Topotecan—Nervous system disorder—Prednisone—asthma	6.44e-05	0.000237	CcSEcCtD
Topotecan—Skin disorder—Prednisone—asthma	6.38e-05	0.000235	CcSEcCtD
Topotecan—Hyperhidrosis—Prednisone—asthma	6.35e-05	0.000234	CcSEcCtD
Topotecan—Asthenia—Hydrocortisone—asthma	6.33e-05	0.000233	CcSEcCtD
Topotecan—ABCG2—Iron uptake and transport—HMOX1—asthma	6.28e-05	0.0105	CbGpPWpGaD
Topotecan—Anorexia—Prednisone—asthma	6.26e-05	0.00023	CcSEcCtD
Topotecan—Pruritus—Hydrocortisone—asthma	6.24e-05	0.00023	CcSEcCtD
Topotecan—Feeling abnormal—Dexamethasone—asthma	6.21e-05	0.000229	CcSEcCtD
Topotecan—Feeling abnormal—Betamethasone—asthma	6.21e-05	0.000229	CcSEcCtD
Topotecan—Gastrointestinal pain—Dexamethasone—asthma	6.17e-05	0.000227	CcSEcCtD
Topotecan—Gastrointestinal pain—Betamethasone—asthma	6.17e-05	0.000227	CcSEcCtD
Topotecan—Hypersensitivity—Triamcinolone—asthma	6.12e-05	0.000225	CcSEcCtD
Topotecan—Hypersensitivity—Methylprednisolone—asthma	6.11e-05	0.000225	CcSEcCtD
Topotecan—Diarrhoea—Hydrocortisone—asthma	6.04e-05	0.000222	CcSEcCtD
Topotecan—Urticaria—Dexamethasone—asthma	5.99e-05	0.00022	CcSEcCtD
Topotecan—Urticaria—Betamethasone—asthma	5.99e-05	0.00022	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Prednisone—asthma	5.98e-05	0.00022	CcSEcCtD
Topotecan—Dizziness—Prednisolone—asthma	5.98e-05	0.00022	CcSEcCtD
Topotecan—Asthenia—Triamcinolone—asthma	5.96e-05	0.000219	CcSEcCtD
Topotecan—Body temperature increased—Betamethasone—asthma	5.96e-05	0.000219	CcSEcCtD
Topotecan—Abdominal pain—Betamethasone—asthma	5.96e-05	0.000219	CcSEcCtD
Topotecan—Abdominal pain—Dexamethasone—asthma	5.96e-05	0.000219	CcSEcCtD
Topotecan—Body temperature increased—Dexamethasone—asthma	5.96e-05	0.000219	CcSEcCtD
Topotecan—Asthenia—Methylprednisolone—asthma	5.95e-05	0.000219	CcSEcCtD
Topotecan—Paraesthesia—Prednisone—asthma	5.9e-05	0.000217	CcSEcCtD
Topotecan—Pruritus—Triamcinolone—asthma	5.88e-05	0.000216	CcSEcCtD
Topotecan—Pruritus—Methylprednisolone—asthma	5.87e-05	0.000216	CcSEcCtD
Topotecan—Dizziness—Hydrocortisone—asthma	5.84e-05	0.000215	CcSEcCtD
Topotecan—Dyspepsia—Prednisone—asthma	5.78e-05	0.000213	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—SERPINE1—asthma	5.78e-05	0.00963	CbGpPWpGaD
Topotecan—Decreased appetite—Prednisone—asthma	5.71e-05	0.00021	CcSEcCtD
Topotecan—Rash—Prednisolone—asthma	5.7e-05	0.00021	CcSEcCtD
Topotecan—Dermatitis—Prednisolone—asthma	5.69e-05	0.00021	CcSEcCtD
Topotecan—Diarrhoea—Methylprednisolone—asthma	5.67e-05	0.000209	CcSEcCtD
Topotecan—Fatigue—Prednisone—asthma	5.66e-05	0.000208	CcSEcCtD
Topotecan—Headache—Prednisolone—asthma	5.66e-05	0.000208	CcSEcCtD
Topotecan—Constipation—Prednisone—asthma	5.62e-05	0.000207	CcSEcCtD
Topotecan—Vomiting—Hydrocortisone—asthma	5.61e-05	0.000207	CcSEcCtD
Topotecan—Rash—Hydrocortisone—asthma	5.57e-05	0.000205	CcSEcCtD
Topotecan—Dermatitis—Hydrocortisone—asthma	5.56e-05	0.000205	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—BCL2—asthma	5.53e-05	0.00922	CbGpPWpGaD
Topotecan—Headache—Hydrocortisone—asthma	5.53e-05	0.000204	CcSEcCtD
Topotecan—Dizziness—Triamcinolone—asthma	5.5e-05	0.000202	CcSEcCtD
Topotecan—Dizziness—Methylprednisolone—asthma	5.48e-05	0.000202	CcSEcCtD
Topotecan—Feeling abnormal—Prednisone—asthma	5.41e-05	0.000199	CcSEcCtD
Topotecan—Asthenia—Dexamethasone—asthma	5.41e-05	0.000199	CcSEcCtD
Topotecan—Asthenia—Betamethasone—asthma	5.41e-05	0.000199	CcSEcCtD
Topotecan—Gastrointestinal pain—Prednisone—asthma	5.37e-05	0.000198	CcSEcCtD
Topotecan—Nausea—Prednisolone—asthma	5.37e-05	0.000198	CcSEcCtD
Topotecan—Pruritus—Dexamethasone—asthma	5.34e-05	0.000196	CcSEcCtD
Topotecan—Pruritus—Betamethasone—asthma	5.34e-05	0.000196	CcSEcCtD
Topotecan—Vomiting—Triamcinolone—asthma	5.28e-05	0.000194	CcSEcCtD
Topotecan—Vomiting—Methylprednisolone—asthma	5.27e-05	0.000194	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	5.26e-05	0.00876	CbGpPWpGaD
Topotecan—Nausea—Hydrocortisone—asthma	5.24e-05	0.000193	CcSEcCtD
Topotecan—Rash—Triamcinolone—asthma	5.24e-05	0.000193	CcSEcCtD
Topotecan—Dermatitis—Triamcinolone—asthma	5.24e-05	0.000193	CcSEcCtD
Topotecan—Rash—Methylprednisolone—asthma	5.23e-05	0.000192	CcSEcCtD
Topotecan—Dermatitis—Methylprednisolone—asthma	5.22e-05	0.000192	CcSEcCtD
Topotecan—Urticaria—Prednisone—asthma	5.22e-05	0.000192	CcSEcCtD
Topotecan—Headache—Triamcinolone—asthma	5.21e-05	0.000192	CcSEcCtD
Topotecan—Headache—Methylprednisolone—asthma	5.2e-05	0.000191	CcSEcCtD
Topotecan—Body temperature increased—Prednisone—asthma	5.19e-05	0.000191	CcSEcCtD
Topotecan—Abdominal pain—Prednisone—asthma	5.19e-05	0.000191	CcSEcCtD
Topotecan—Diarrhoea—Betamethasone—asthma	5.16e-05	0.00019	CcSEcCtD
Topotecan—Diarrhoea—Dexamethasone—asthma	5.16e-05	0.00019	CcSEcCtD
Topotecan—CYP3A4—Estrogen metabolism—NQO1—asthma	5.1e-05	0.0085	CbGpPWpGaD
Topotecan—Dizziness—Betamethasone—asthma	4.99e-05	0.000184	CcSEcCtD
Topotecan—Dizziness—Dexamethasone—asthma	4.99e-05	0.000184	CcSEcCtD
Topotecan—Nausea—Triamcinolone—asthma	4.94e-05	0.000182	CcSEcCtD
Topotecan—Nausea—Methylprednisolone—asthma	4.93e-05	0.000181	CcSEcCtD
Topotecan—Hypersensitivity—Prednisone—asthma	4.84e-05	0.000178	CcSEcCtD
Topotecan—Vomiting—Betamethasone—asthma	4.79e-05	0.000176	CcSEcCtD
Topotecan—Vomiting—Dexamethasone—asthma	4.79e-05	0.000176	CcSEcCtD
Topotecan—Rash—Dexamethasone—asthma	4.75e-05	0.000175	CcSEcCtD
Topotecan—Rash—Betamethasone—asthma	4.75e-05	0.000175	CcSEcCtD
Topotecan—Dermatitis—Dexamethasone—asthma	4.75e-05	0.000175	CcSEcCtD
Topotecan—Dermatitis—Betamethasone—asthma	4.75e-05	0.000175	CcSEcCtD
Topotecan—Headache—Dexamethasone—asthma	4.72e-05	0.000174	CcSEcCtD
Topotecan—Headache—Betamethasone—asthma	4.72e-05	0.000174	CcSEcCtD
Topotecan—Asthenia—Prednisone—asthma	4.71e-05	0.000173	CcSEcCtD
Topotecan—Pruritus—Prednisone—asthma	4.65e-05	0.000171	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—asthma	4.58e-05	0.00764	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—asthma	4.56e-05	0.00759	CbGpPWpGaD
Topotecan—Diarrhoea—Prednisone—asthma	4.49e-05	0.000165	CcSEcCtD
Topotecan—Nausea—Betamethasone—asthma	4.48e-05	0.000165	CcSEcCtD
Topotecan—Nausea—Dexamethasone—asthma	4.48e-05	0.000165	CcSEcCtD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—HMOX1—asthma	4.46e-05	0.00743	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—PTEN—asthma	4.4e-05	0.00734	CbGpPWpGaD
Topotecan—Dizziness—Prednisone—asthma	4.34e-05	0.00016	CcSEcCtD
Topotecan—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—asthma	4.21e-05	0.00701	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—EDN1—asthma	4.2e-05	0.007	CbGpPWpGaD
Topotecan—Vomiting—Prednisone—asthma	4.18e-05	0.000154	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	4.14e-05	0.0069	CbGpPWpGaD
Topotecan—Rash—Prednisone—asthma	4.14e-05	0.000152	CcSEcCtD
Topotecan—Dermatitis—Prednisone—asthma	4.14e-05	0.000152	CcSEcCtD
Topotecan—ABCB1—Allograft Rejection—PRF1—asthma	4.13e-05	0.00688	CbGpPWpGaD
Topotecan—Headache—Prednisone—asthma	4.11e-05	0.000151	CcSEcCtD
Topotecan—CYP3A4—Metapathway biotransformation—HNMT—asthma	4.08e-05	0.0068	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—SMAD3—asthma	4e-05	0.00666	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	3.92e-05	0.00654	CbGpPWpGaD
Topotecan—CYP3A4—Estrogen metabolism—GSTM1—asthma	3.91e-05	0.00652	CbGpPWpGaD
Topotecan—Nausea—Prednisone—asthma	3.9e-05	0.000144	CcSEcCtD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	3.8e-05	0.00633	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—asthma	3.73e-05	0.00621	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—FOXP3—asthma	3.63e-05	0.00605	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TNF—asthma	3.55e-05	0.00591	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—C5—asthma	3.51e-05	0.00585	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—TRPA1—asthma	3.43e-05	0.00572	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—LEP—asthma	3.42e-05	0.00569	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—HLA-G—asthma	3.3e-05	0.0055	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—NOS2—asthma	3.18e-05	0.0053	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—asthma	3.13e-05	0.00522	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL13—asthma	3.11e-05	0.00518	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—ALDH2—asthma	3.05e-05	0.00508	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL17A—asthma	2.86e-05	0.00477	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—IL6—asthma	2.75e-05	0.00458	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—asthma	2.68e-05	0.00447	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL12B—asthma	2.66e-05	0.00443	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL5—asthma	2.66e-05	0.00443	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—HLA-DPB1—asthma	2.64e-05	0.00439	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CD40—asthma	2.54e-05	0.00423	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CTLA4—asthma	2.5e-05	0.00417	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	2.42e-05	0.00403	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—HMOX1—asthma	2.41e-05	0.00401	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—AGTR1—asthma	2.32e-05	0.00387	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—RAD50—asthma	2.28e-05	0.00381	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—EDN1—asthma	2.27e-05	0.00378	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—HLA-DQA1—asthma	2.2e-05	0.00367	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—SMAD3—asthma	2.16e-05	0.0036	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—HLA-DQB1—asthma	2.06e-05	0.00343	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—IL1R1—asthma	2.04e-05	0.00339	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—asthma	2e-05	0.00333	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CD86—asthma	1.98e-05	0.0033	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC26A4—asthma	1.97e-05	0.00329	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—CAT—asthma	1.95e-05	0.00326	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL10—asthma	1.94e-05	0.00324	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CD40LG—asthma	1.94e-05	0.00324	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL4—asthma	1.89e-05	0.00315	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—TRPA1—asthma	1.86e-05	0.00309	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—LEP—asthma	1.85e-05	0.00308	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—asthma	1.84e-05	0.00307	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—SLC30A8—asthma	1.8e-05	0.00301	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ATP4A—asthma	1.8e-05	0.00301	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL2RA—asthma	1.73e-05	0.00289	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—NOS2—asthma	1.72e-05	0.00287	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—C3—asthma	1.72e-05	0.00286	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—HLA-DRB1—asthma	1.57e-05	0.00261	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—asthma	1.45e-05	0.00242	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LTC4S—asthma	1.29e-05	0.00214	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—asthma	1.24e-05	0.00207	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—asthma	1.22e-05	0.00203	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—CARM1—asthma	1.21e-05	0.00202	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IFNG—asthma	1.14e-05	0.0019	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LTA4H—asthma	1.12e-05	0.00186	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	1.1e-05	0.00183	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC26A4—asthma	1.07e-05	0.00178	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CXCL8—asthma	1.06e-05	0.00177	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—ALDH2—asthma	1.06e-05	0.00177	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	1.05e-05	0.00176	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL1B—asthma	1.02e-05	0.0017	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL2—asthma	1.02e-05	0.00169	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTT1—asthma	1.01e-05	0.00168	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—asthma	1e-05	0.00167	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—asthma	9.97e-06	0.00166	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ATP4A—asthma	9.76e-06	0.00163	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—SLC30A8—asthma	9.76e-06	0.00163	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ARG1—asthma	9.75e-06	0.00162	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	9.59e-06	0.0016	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ADCY2—asthma	8.99e-06	0.0015	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALDH7A1—asthma	8.81e-06	0.00147	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—VEGFA—asthma	8.63e-06	0.00144	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	8.55e-06	0.00143	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ARG2—asthma	8.45e-06	0.00141	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—asthma	8.01e-06	0.00133	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TGFB1—asthma	7.92e-06	0.00132	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—HMOX1—asthma	7.56e-06	0.00126	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TNF—asthma	7.4e-06	0.00123	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALOX5AP—asthma	7e-06	0.00117	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALOX15—asthma	7e-06	0.00117	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTP1—asthma	6.99e-06	0.00117	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LTC4S—asthma	6.95e-06	0.00116	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—GSTP1—asthma	6.9e-06	0.00115	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CHAT—asthma	6.68e-06	0.00111	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—CARM1—asthma	6.56e-06	0.00109	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTM1—asthma	6.43e-06	0.00107	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—GSTM1—asthma	6.34e-06	0.00106	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LTA4H—asthma	6.03e-06	0.001	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALOX5—asthma	5.95e-06	0.000992	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—asthma	5.69e-06	0.000949	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CARM1—asthma	5.68e-06	0.000947	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—DCN—asthma	5.6e-06	0.000933	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALDH2—asthma	5.45e-06	0.000908	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	5.41e-06	0.000901	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ARG1—asthma	5.27e-06	0.000878	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTT1—asthma	5.18e-06	0.000863	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ADCY2—asthma	4.86e-06	0.00081	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALDH7A1—asthma	4.77e-06	0.000794	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—asthma	4.72e-06	0.000786	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ARG2—asthma	4.57e-06	0.000761	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—POMC—asthma	4.54e-06	0.000757	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ALB—asthma	4.54e-06	0.000757	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NQO1—asthma	4.3e-06	0.000717	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LTC4S—asthma	4.28e-06	0.000714	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	4.26e-06	0.00071	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ADCY2—asthma	4.21e-06	0.000702	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—HMOX1—asthma	4.09e-06	0.000681	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	3.91e-06	0.000652	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—asthma	3.83e-06	0.000639	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALOX15—asthma	3.79e-06	0.000631	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALOX5AP—asthma	3.79e-06	0.000631	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LTA4H—asthma	3.71e-06	0.000619	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—asthma	3.65e-06	0.000608	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CHAT—asthma	3.61e-06	0.000602	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTP1—asthma	3.59e-06	0.000598	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HMOX1—asthma	3.54e-06	0.00059	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ITPR1—asthma	3.53e-06	0.000589	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CAT—asthma	3.49e-06	0.000582	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTM1—asthma	3.3e-06	0.00055	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PLA2G4A—asthma	3.3e-06	0.00055	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ARG1—asthma	3.25e-06	0.000541	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALOX5—asthma	3.22e-06	0.000537	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CARM1—asthma	3.07e-06	0.000512	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPP2CA—asthma	3.04e-06	0.000506	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—DCN—asthma	3.03e-06	0.000504	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALDH2—asthma	2.94e-06	0.000491	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALDH7A1—asthma	2.94e-06	0.000489	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ARG2—asthma	2.81e-06	0.000469	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTT1—asthma	2.8e-06	0.000467	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ALB—asthma	2.45e-06	0.000409	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALOX5AP—asthma	2.33e-06	0.000389	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALOX15—asthma	2.33e-06	0.000389	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—POMC—asthma	2.33e-06	0.000389	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NQO1—asthma	2.33e-06	0.000388	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ADCY2—asthma	2.28e-06	0.00038	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CHAT—asthma	2.23e-06	0.000371	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALB—asthma	2.13e-06	0.000354	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NOS3—asthma	2.03e-06	0.000339	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALOX5—asthma	1.98e-06	0.000331	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTP1—asthma	1.94e-06	0.000324	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HMOX1—asthma	1.91e-06	0.000319	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ITPR1—asthma	1.91e-06	0.000318	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CARM1—asthma	1.89e-06	0.000315	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CAT—asthma	1.89e-06	0.000315	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—DCN—asthma	1.86e-06	0.000311	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—asthma	1.86e-06	0.00031	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALDH2—asthma	1.81e-06	0.000302	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTM1—asthma	1.78e-06	0.000297	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PLA2G4A—asthma	1.78e-06	0.000297	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTT1—asthma	1.73e-06	0.000288	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPP2CA—asthma	1.64e-06	0.000274	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTEN—asthma	1.62e-06	0.00027	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NQO1—asthma	1.43e-06	0.000239	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ADCY2—asthma	1.4e-06	0.000234	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—POMC—asthma	1.26e-06	0.00021	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTP1—asthma	1.2e-06	0.000199	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HMOX1—asthma	1.18e-06	0.000197	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ITPR1—asthma	1.18e-06	0.000196	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CAT—asthma	1.16e-06	0.000194	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALB—asthma	1.15e-06	0.000192	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NOS3—asthma	1.1e-06	0.000183	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTM1—asthma	1.1e-06	0.000183	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PLA2G4A—asthma	1.1e-06	0.000183	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPP2CA—asthma	1.01e-06	0.000169	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—asthma	1.01e-06	0.000168	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTEN—asthma	8.77e-07	0.000146	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—POMC—asthma	7.77e-07	0.000129	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALB—asthma	7.08e-07	0.000118	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NOS3—asthma	6.77e-07	0.000113	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—asthma	6.2e-07	0.000103	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTEN—asthma	5.4e-07	9.01e-05	CbGpPWpGaD
